首页 | 本学科首页   官方微博 | 高级检索  
     

奥沙利铂相关性肺损伤的文献分析
引用本文:陈佳音,马洁,童刚领,刘超然,王立军. 奥沙利铂相关性肺损伤的文献分析[J]. 中国医院药学杂志, 2021, 41(10): 1059-1063. DOI: 10.13286/j.1001-5213.2021.10.14
作者姓名:陈佳音  马洁  童刚领  刘超然  王立军
作者单位:1. 北京大学深圳医院, 药学部, 广东 深圳 518036;2. 北京大学深圳医院, 肿瘤科, 广东 深圳 518036
基金项目:广东省科技创新战略专项资金(编号:2018A0303100026)
摘    要:目的:探讨奥沙利铂相关性肺损伤的发生特点、临床治疗及转归等情况,为临床安全合理用药提供参考.方法:检索PubMed、Web of Science、中国知网、维普和万方等数据库中奥沙利铂肺毒性的相关病例报道并进行统计汇总分析.结果:共收集到29篇文献的32例个案报道,以亚洲报道最多.患者发生肺损伤的中位时间为7.5±4....

关 键 词:奥沙利铂  肺毒性  间质性肺炎  肺纤维化  药物不良反应
收稿时间:2020-09-11

Literature analysis of lung injury induced by oxaliplatin
CHEN Jia-yin,MA Jie,TONG Gang-ling,LIU Chao-ran,WANG Li-jun. Literature analysis of lung injury induced by oxaliplatin[J]. Chinese Journal of Hospital Pharmacy, 2021, 41(10): 1059-1063. DOI: 10.13286/j.1001-5213.2021.10.14
Authors:CHEN Jia-yin  MA Jie  TONG Gang-ling  LIU Chao-ran  WANG Li-jun
Affiliation:1. Department of Pharmacy, Peking University Shenzhen Hospital, Guangdong Shenzhen 518036, China;2. Department of Oncology, Peking University Shenzhen Hospital, Guangdong Shenzhen 518036, China
Abstract:OBJECTIVE To explore the occurrence, characteristics, treatments and outcomes of lung injury induced by oxaliplatin,and to provide rationales for its rational clinical application.METHODS Case reports were collected by searching the databases of PubMed, Web of Science, CNKI, VIP and WanFang.AU selected articles were further statistically analyzed.RESULTS A total of 32 case reports from 29 literature items were included, with the most reports in Asia.The median occurring time of adverse drug reaction (ADR) was (7.5±4.5) chemotherapeutic cycles.The most common clinical symptoms included dyspnea, cough and fever.Auscultation revealed inspiratory crackles and imaging features showed ground-glass opacities and diffuse infiltrates.All 32 cases were confirmed as interstitial lung disease, 13 of which showed lung fibrosis.The major treatment was to provide intravenous/oral glucocorticoid, sometimes supplemented by oxygen or mechanical ventilation.Finally 19 cases were relieved and 13 cases died with a mortality rate of 40.6%.CONCLUSION The pulmonary toxicity of oxaliplatin is rare.However, its mortality rate has remained high.Clinicians and pharmacists should be alert to the possibility of ADRs in order to identify and diagnose them early.
Keywords:Oxaliplatin  lung toxicity  interstitial pneumonia  lung fibrosis  drug adverse reaction  
点击此处可从《中国医院药学杂志》浏览原始摘要信息
点击此处可从《中国医院药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号